mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.004 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.005 |